Rare Primary Brain Tumors in Adults
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Causes, Screening and Diagnosis".
Deadline for manuscript submissions: closed (20 October 2022) | Viewed by 25100
Special Issue Editors
Interests: Clinical and Translational research in primary malignant brain tumors in adults
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Rare primary central nervous system (CNS) tumors in adults remain a medical and research challenge due to their scarcity. However, joining efforts as supported by European Reference Network may help for an optimized medical management of patients in the setting of a large medical community and foster research in this field. A first step toward advancement is high-quality, comprehensive, and updated reviews dedicated to each group of rare primary CNS tumor in adults, including: (i) epidemiology, (ii) biology, (iii) pathology and molecular pathology, (iv) clinical symptoms, (v) radiological features, (vi) treatments and outcome, and (vii) research perspectives.
The main primary rare CNS tumors need to be covered in this Special Issue: (i) medulloblastoma and embryonal tumors, (ii) pineal region tumors, (iii) glioneuronal tumor and rare glial tumors, (iv) ependymal tumors, (v) grade III meningioma and mesenchymal tumors, (vi) primary CNS lymphoma and hematological diseases, (vii) germ cell tumors, (viii) spinal cord tumors, (ix) rare pituitary tumors, and (x) ultra-rare tumors.
Prof. Ahmed Idbaih
Dr. Enrico Franceschi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- brain tumor
- diagnosis
- treatment
- rare